| TARGACEPT DESIGN TARGACEPT INC.
A CORPORATION OF DELAWARE
1210551 17 Mar 2004 | on 21 Jan 2014 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of central nervous system, gastrointestinal, respiratory and inflammatory diseases and disorders, namely: depression and anxiety disorders, attention deficit hyperactivity disorder, Alzheimer's disease, age associated memory impairment, mild cognitive impairment, schizophrenia, cognitive dysfunction in schizophrenia, Parkinson's disease, pain, obesity, addiction, hypertension, asthma, diabetes, inflammatory bowel disease and ulcerative colitis. | | 
